IDX:LIFE Income Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Premiums & Annuity Revenue	2,018,090	1,968,826	1,554,247	2,569,686	2,575,197	3,596,923
Total Interest & Dividend Income	208,125	200,019	460,360	730,589	614,382	581,843
Gain (Loss) on Sale of Investments	454,560	437,207	21,262	98,164	107,929	-187,337
Other Revenue	-	-	-	39,034	136,771	47,243
Total Revenue	2,721,261	2,647,016	2,076,871	3,494,268	3,457,500	4,073,408
Revenue Growth (YoY)	69.28%	27.45%	-40.56%	1.06%	-15.12%	-6.58%
Policy Benefits	1,244,925	1,196,120	763,294	1,956,316	2,154,156	3,124,914
Policy Acquisition & Underwriting Costs	689,218	667,017	618,106	729,924	463,171	383,543
Selling, General & Administrative	286,659	286,307	180,728	494,861	416,129	388,925
Other Operating Expenses	196,293	265,191	220,621	16,903	17,522	48,226
Total Operating Expenses	2,417,095	2,414,635	1,782,749	3,198,004	3,050,978	3,945,608
Operating Income	304,166	232,381	294,122	296,264	406,522	127,800
Currency Exchange Gain (Loss)	-	-	-	-11,011	49,990	2,012
Other Non Operating Income (Expenses)	66,567	66,567	40,048	-	-	-
EBT Excluding Unusual Items	370,733	298,948	334,170	285,253	456,512	129,812
Merger & Restructuring Charges	-8,735	-8,498	-16,238	-	-	-
Gain (Loss) on Sale of Assets	1,735	1,690	1,534	1,669	3,078	4,889
Asset Writedown	-10,533	-10,533	-5,177	2,189	7,219	4,524
Legal Settlements	-	-	128,148	-90,000	-38,148	-
Pretax Income	353,200	281,607	442,437	199,111	428,661	139,225
Income Tax Expense	77,338	75,379	70,748	72,623	60,888	65,401
Net Income	275,862	206,228	371,689	126,488	367,773	73,824
Net Income to Common	275,862	206,228	371,689	126,488	367,773	73,824
Net Income Growth	-4.69%	-44.52%	193.85%	-65.61%	398.18%	-77.69%
Shares Outstanding (Basic)	2,100	2,100	2,100	2,100	2,100	2,100
Shares Outstanding (Diluted)	2,100	2,100	2,100	2,100	2,100	2,100
EPS (Basic)	131.36	98.20	176.99	60.23	175.13	35.15
EPS (Diluted)	131.00	98.00	176.99	60.00	175.13	35.00
EPS Growth	-4.76%	-44.63%	194.99%	-65.74%	400.37%	-77.79%
Free Cash Flow	566,556	510,068	-609,781	-877,184	-1,327,051	883,362
Free Cash Flow Per Share	269.79	242.89	-290.37	-417.71	-631.93	420.65
Dividend Per Share	-	-	160.000	38.000	177.000	34.000
Dividend Growth	-	-	321.05%	-78.53%	420.59%	-86.01%
Operating Margin	11.18%	8.78%	14.16%	8.48%	11.76%	3.14%
Profit Margin	10.14%	7.79%	17.90%	3.62%	10.64%	1.81%
Free Cash Flow Margin	20.82%	19.27%	-29.36%	-25.10%	-38.38%	21.69%
EBITDA	321,830	249,459	309,054	318,760	426,744	151,552
EBITDA Margin	11.83%	9.42%	14.88%	9.12%	12.34%	3.72%
D&A For EBITDA	17,664	17,078	14,932	22,496	20,222	23,752
EBIT	304,166	232,381	294,122	296,264	406,522	127,800
EBIT Margin	11.18%	8.78%	14.16%	8.48%	11.76%	3.14%
Effective Tax Rate	21.90%	26.77%	15.99%	36.47%	14.20%	46.98%
Revenue as Reported	-	-	-	3,495,887	3,521,147	4,091,250

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.